A recent study indicates that people who come off new weight-loss injections like Mounjaro or Wegovy may regain lost weight much more quickly than those who end traditional diet and exercise regimens.
Findings released in a leading health publication points out that while obese individuals frequently drop about a fifth of their body weight while on the medication, the weight is regained at an estimated rate of 0.8 kg per month once they quit.
"People buying these medications must be aware of the danger of quick rebound weight gain when the therapy ends," warns researcher Dr. Susan Jebb.
This pace of recovery means a reversion to original mass in about one and a half years.
Analyzing Treatments
The analysis, which reviewed dozens of trials involving over 9,000 of participants, contrasted the results of the injectable medications with older methods.
The team note that people who shed pounds through diet and exercise generally experience a slower creep back—approximately 100 grams monthly—once they finish.
Understanding the Quick Rebound
Doctors suggest the mode of action of the jabs accounts for the accelerated rebound.
GLP-1 drugs copy a natural hormone called glucagon-like peptide-1, which helps regulate hunger.
"Artificially providing GLP-1 concentrations far above than the body's typical production might result in the body to generate a reduced amount of its endogenous GLP-1, and may also diminish sensitivity to its actions," said Dr. Adam Collins, a nutrition specialist.
"Withdrawal of this GLP-1 'fix' leads to hunger is no longer kept in check, making binge eating a significant risk."
An Ongoing Disease?
Health authorities suggest the jabs for people with weight-linked health risks, alongside recommended diet and exercise modifications.
Many experts argue that, considering the significant potential of relapse, the therapy might need to be long-term.
This view is echoed by drug manufacturers, who state that the findings "underscore the persistent character of obesity," akin to managing conditions like diabetes.
User Experiences
Individuals who have stopped the jabs explain a intense resurgence of appetite.
"It was like a trigger activating and I was suddenly extremely hungry," recalled an individual.
This challenge is worsened if individuals have not established lasting dietary or behavioural modifications during therapy.
Widespread Interest
Recent estimates indicate that millions of people in the UK have used these injections in the past year, with interest continuing to grow.
- Use is greater among women than males.
- The 40s and 50s demographic shows the highest usage rates.
- Many obtain the medications through private prescriptions rather than public health services.
In conclusion, clinicians emphasize that while the jabs are powerful agents for shedding pounds, they are not a standalone cure and lasting health benefits likely depends on integrated lifestyle changes.
